Sarasota Memorial Hospital has been ranked #1 in the nation for preventing readmissions among heart bypass patients, according to Becker’s Hospital Review, with federal data showing SMH with the lowest rate of unplanned hospital visits following coronary artery bypass graft (CABG) surgery of all hospitals evaluated.
Women with advanced or recurring ovarian, peritoneal, or fallopian tube cancer may be eligible to participate in a new clinical trial offered by Sarasota Memorial’s Kolschowsky Research and Education Institute.
In 2025, roughly 313,780 men in the US will learn they have prostate cancer and 35,770 will die from it. Since 2014, that rate has only been increasing. But a new targeted therapy called Pluvicto is changing the game.
Sarasota Memorial Health Care System (SMH) has once again been recognized as one of the best employers in Florida, earning a spot on Forbes’ 2025 list of America’s Best-in-State Employers.
Sarasota Memorial was named by Newsweek as one of “America’s Best Physical Rehabilitation Centers” today.
